Director · Dianthus Therapeutics, Inc. /DE/ · Dianthus Therapeutics, Inc. /DE/ — Stock Option (Right to Buy)
Side
M
Value
—
Shares
6,500
Price
—
Executed
Aug 10, 2026
Disclosed
Aug 11, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 10 executedAug 11, 2026 disclosed
DNTH · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Dianthus Therapeutics, Inc. /DE/ — Stock Option (Right to Buy)
Ticker
DNTH
Shares
6,500
Price per share
$0
Execution date (reported)
Aug 10, 2026
Owned after transaction
0 shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
1
What this establishes
McGeorge Anne filed this Form 4 reporting a option exercise of DNTH on Aug 10, 2026. It became public on Aug 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
McGeorge Annecik:0001779934
Issuer
Dianthus Therapeutics, Inc. /DE/cik:0001690585
Revision history · 0
No field has changed since this record was first ingested.
